Workflow
GoHealth(GOCO)
icon
Search documents
INVESTOR ALERT: Investigation of GoHealth, Inc. (GOCO) Announced by Holzer & Holzer, LLC
GlobeNewswire News Room· 2025-06-25 17:11
ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO) complied with federal securities laws. On May 1, 2025, the Department of Justice filed a complaint against GoHealth and others alleging that the Company, among other things, “knowingly entered into unlawful agreements to present false or fraudulent claims to the Government and performed acts in furtherance of this conspiracy.” Following this news, the price of ...
GoHealth (GOCO) Conference Transcript
2025-06-12 15:00
GoHealth (GOCO) Conference Summary Company Overview - GoHealth specializes in helping Medicare consumers navigate their insurance options, particularly Medicare Advantage plans, which are growing rapidly in the market [4][15] - The company has been in operation for over 20 years and has facilitated over 30 million shopping experiences for Medicare consumers [9] Core Business Model - GoHealth provides a personalized shopping experience for Medicare consumers, focusing on their specific healthcare needs, such as doctor networks and drug coverage [7][10] - The company operates primarily through a telephonic model, where 100% of enrollments occur via live conversations with licensed agents [14] Market Dynamics - The Medicare Advantage market is growing at a rate of 5-7% annually, with approximately 68 million consumers in Medicare, half of whom are enrolled in Medicare Advantage plans [15][16] - Over 11,000 new Medicare consumers enter the market daily, with a majority opting for Medicare Advantage plans [16] Competitive Advantage - GoHealth claims to have the lowest customer acquisition cost (CAC) in the industry, being 17% better than public peers and nearly 50% better than the industry average [37] - The company utilizes a proprietary Plan Fit tool that leverages data from 30 million shopping experiences to match consumers with the best insurance plans [33][40] Recent Challenges and Strategic Adjustments - The company has faced challenges due to health plans being tentative about growth under the current economic model, leading to a pullback in writing new Medicare Advantage business [46][47] - GoHealth is diversifying its offerings by introducing guaranteed acceptance life insurance to stabilize agent productivity during slower periods in the Medicare market [55][58] Financial Performance - GoHealth reported material improvements in revenue and adjusted EBITDA for Q1 2024 compared to Q1 2025, driven by efficient resource deployment and an acquisition [38] - The company is working on resetting covenants with lenders due to changes in its business model and market dynamics [49][53] Future Outlook - The upcoming Annual Enrollment Period (AEP) is expected to be highly disruptive, which could lead to increased demand for GoHealth's services as consumers seek new plans [66][68] - The company anticipates a significant increase in revenue from its life insurance business in Q2 and Q3 2025 [63] Key Differentiators - GoHealth emphasizes an unbiased shopping experience, ensuring that agents recommend the best plans for consumers, even if it means advising them to stay on their current plans [21][27] - The company focuses on building long-term relationships with consumers, expecting them to return for multiple shopping experiences throughout their Medicare tenure [30] Conclusion - GoHealth is positioned in a growing market with a unique business model that prioritizes consumer needs and leverages technology to enhance efficiency and customer experience [39][88]
Bragar Eagel & Squire, P.C. Is Investigating GoHealth and Abacus and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-06-10 01:00
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO) and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided. GoHealth, Inc. (NASDAQ:GOCO) On May 1, 2025, t ...
Rosen Law Firm Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation - GOCO
Prnewswire· 2025-05-30 18:17
NEW YORK, May 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen ...
Regulatory Winds & Execution Catalyze GoHealth's Upside
Seeking Alpha· 2025-05-28 16:13
We initiate coverage on GoHealth, Inc. (NASDAQ: NASDAQ: GOCO ) with a Strong Buy and $20 PT. GoHealth is a leading digital Medicare & health insurance brokerage marketplace utilizing AI-based plan optimization and consumer activation in the U.S. Our Strong Buy rating isMoretus Research delivers state-of-the-art, buy-side quality equity research for serious investors seeking clarity, conviction, and alpha. Focused on U.S. public markets, Moretus applies a structured, repeatable framework to identify companie ...
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire News Room· 2025-05-24 13:15
Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GoHealth, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Investigation and Class Action - Shareholders who purchased GoHealth securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to GoHealth [2]. Group 2: Allegations and Stock Impact - The U.S. Department of Justice announced charges against GoHealth, alleging that from 2016 to 2021, the company was involved in illegal kickbacks totaling hundreds of millions of dollars to brokers for enrollments in Medicare Advantage plans [3]. - Following the announcement of these charges, GoHealth's stock price dropped by 10.3% on May 1, 2025, and an additional 6.7% on May 2, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4].
INVESTOR ALERT: Cohen Milstein Investigates Claims Against GoHealth, Inc. (GOCO) on Behalf of Investors
GlobeNewswire News Room· 2025-05-20 17:59
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC is investigating GoHealth, Inc. (NASDAQ: GOCO) and certain of its officers and/or directors for potential securities fraud or other securities violations following a complaint recently filed by the Department of Justice alleging unlawful business practices involving a Medicare Advantage kickback scheme. If you are an investor in GoHealth, Inc. and purchased shares of GoHealth between 2016 and May 1, 2025, please consider contact ...
GoHealth(GOCO) - 2025 Q1 - Quarterly Report
2025-05-16 21:01
Financial Performance - Net revenues for Q1 2025 were $220,972,000, a 19% increase from $185,600,000 in Q1 2024[26] - Operating expenses totaled $214,303,000 in Q1 2025, up from $189,632,000 in Q1 2024, reflecting an increase of 13%[26] - The company reported an income from operations of $6,669,000 in Q1 2025, compared to a loss of $4,032,000 in Q1 2024[26] - Net loss attributable to GoHealth, Inc. was $4,408,000 in Q1 2025, an improvement from a net loss of $9,216,000 in Q1 2024[26] - The net income (loss) per share for Class A common stock was $(0.52) in Q1 2025, compared to $(1.04) in Q1 2024[26] - Comprehensive loss for Q1 2025 was $9,905,000, an improvement from a comprehensive loss of $21,351,000 in Q1 2024[30] - For the three months ended March 31, 2025, GoHealth reported a net loss of $9,786 thousand, compared to a net loss of $21,346 thousand for the same period in 2024, indicating a 54.2% improvement in net loss year-over-year[39] - Adjusted EBITDA for Q1 2025 was $42.060 million, a 56.4% increase from $26.894 million in Q1 2024, with an adjusted EBITDA margin of 19.0%[165] Assets and Liabilities - Total assets decreased to $1,382,067,000 as of March 31, 2025, down from $1,488,423,000 at the end of 2024[32] - Cash and cash equivalents decreased to $22,153,000 as of March 31, 2025, from $40,921,000 at the end of 2024[32] - Current liabilities decreased to $233,399,000 as of March 31, 2025, compared to $338,052,000 at the end of 2024[32] - The company had a total stockholders' equity of $397,086,000 as of March 31, 2025, down from $405,438,000 at the end of 2024[32] - As of March 31, 2025, the total long-term debt of the company is $446.4 million, a slight decrease from $447.9 million as of December 31, 2024[62] - The company reported a net cash used in operating activities of $12,405 thousand for Q1 2025, compared to net cash provided of $12,512 thousand in Q1 2024[39] - The company raised substantial doubt about its ability to continue as a going concern due to insufficient funding to meet obligations within the next twelve months[214] Revenue Sources - Medicare revenue increased to $219.404 million in Q1 2025, up 18.5% from $185.026 million in Q1 2024, driven by a significant rise in agency revenue[100] - Agency revenue, which includes commission revenue and partner marketing, reached $187.633 million in Q1 2025, a substantial increase of 89.4% compared to $99.124 million in Q1 2024[100] - The increase in net revenues was primarily driven by an $88.5 million rise in agency revenue, partially offset by a $54.1 million decrease in non-agency revenue[147] - The Company recognized $41.6 million in revenue from deferred revenue during Q1 2025, compared to $34.9 million in Q1 2024[110] Expenses - Share-based compensation increased to $2,803 thousand in Q1 2025 from $1,783 thousand in Q1 2024, reflecting a 57.0% increase[39] - Marketing and advertising expenses rose to $67.415 million in Q1 2025, a 27.7% increase from $52.775 million in Q1 2024, aimed at generating more qualified prospects[149] - General and administrative expenses increased by 33.9% to $22.656 million in Q1 2025, primarily due to costs associated with the e-TeleQuote acquisition[153] - Interest expense decreased to $15.954 million in Q1 2025 from $17.951 million in Q1 2024, reflecting a reduction in interest rates on the Term Loan Facility[155] Operational Changes - The company is currently in compliance with its financial covenants but faces substantial doubt about its ability to continue as a going concern due to potential liquidity constraints[50] - The company has developed mitigating plans to address potential liquidity constraints, including cost control measures and renegotiation of existing debt arrangements[50] - The company is actively looking to terminate or sublease certain office spaces and call centers as part of its cost savings initiatives[60] - The company completed the acquisition of e-TeleQuote on September 30, 2024, and excluded it from the internal control evaluation for the quarter ended March 31, 2025[207] Customer Engagement - Submissions increased to 303,026 in Q1 2025 from 216,148 in Q1 2024, indicating a significant growth in customer engagement[168] - For the three months ended March 31, 2025, the number of Submissions increased to 303,026, up 40.2% from 216,148 in the same period of 2024, primarily due to enhanced marketing efforts and increased agent headcount following the e-TeleQuote acquisition[170] Legal and Compliance - The company is contesting a derivative action related to alleged breaches of fiduciary duty, which may impact its financial condition[120] - The company is subject to various legal proceedings that could adversely affect its business and financial condition[213] - The company’s internal control over financial reporting was evaluated as effective as of March 31, 2025[205]
Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q1
Newsfile· 2025-05-14 20:36
Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q1May 14, 2025 4:36 PM EDT | Source: Reportable, Inc.Dallas, Texas--(Newsfile Corp. - May 14, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a strong first quarter in 2025, highlighted by substantial revenue growth and operational efficiencies. Net revenues surged 19.1% year-over-year to $221.0M, driven by a 40.2% increase i ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
GlobeNewswire News Room· 2025-05-13 16:15
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 1, 2025, th ...